Evidence map›Paper›PMID 30194602›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2018

Serpins in Venous Thrombosis and Venous Thrombus Resolution.

Subhradip Mukhopadhyay, Tierra A Johnson, Rajabrata Sarkar, Toni M Antalis

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The role of fibrinolysis in vascular diseases in UK biobank.Journal of thrombosis and thrombolysis · 2023
    Article
  5. Article
  6. LncRNA SERPINB9P1 expression and polymorphisms are associated with ischemic stroke in a Chinese Han population.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Subhradip MukhopadhyayCenter for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD, USA.
Tierra A JohnsonCenter for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD, USA.
Rajabrata SarkarCenter for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD, USA.
Toni M AntalisCenter for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD, USA. tantalis@som.umaryland.edu.
University of Maryland, Baltimore · US

Funding

Vascular Biology Training ProgramT32HL007698 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI Rosemary A Kozar, Dudley K. Strickland · 1991 to 2026
$8.7M
Proteolytic Pathways in Venous Thrombus ResolutionI01BX001921 · VA · BALTIMORE VA MEDICAL CENTER · PI ANTALIS, TONI M · 2013 to 2025
–
BLRD VA I01 BX001921NHLBI NIH HHS T32 HL007698
6 · The paper itself

Abstract

Several serpins function as potent inhibitors of thrombolytic serine proteases. Venous thrombosis is a common and debilitating condition whose incidence is on the rise. Studies using genetically modified mice and inhibitors have shown that the plasminogen activator inhibitors (PAI), PAI-1 and PAI-2, are primary regulators of plasminogen activation and contribute to regulating the resolution of experimental venous thrombi, via inflammatory mechanisms, vascular remodeling, and inhibition of fibrinolysis. Therapies to accelerate venous thrombus resolution would be beneficial, since delayed or incomplete clot resolution frequently leads to postthrombotic syndrome, a long-term complication associated with debilitating limb swelling, pain, and recurrent skin ulceration. Here we describe a useful and reproducible mouse model for the study of venous thrombus resolution involving ligation of the inferior vena cava and elucidation of the molecular and cellular determinants of venous thrombus formation and resolution.

Indexed as

FibrinolysisAnimalsDisease Models, AnimalMicePlasminogenPlasminogen Activator Inhibitor 2Serpin E2Thrombolytic TherapyVenous ThrombosisPlasminogenPlasminogen Activator Inhibitor 2Serpin E2Serpine2 protein, mouseDeep vein thrombosis (DVT)Mouse modelPAI-1PAI-2Plasminogen activatorPostthrombotic syndromeuPAVena cavaVenous thrombus resolution

Identifiers

PMID30194602
PMCPMC6400456
OpenAlexW2889682013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.